CM
NTRP

Caption Management’s Neurotrope, Inc. Common NTRP Stock Holding History

Caption Management’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,400
Closed -$15K – 1075
2019
Q3 		$15K Hold
19,400
– – ﹤0.01% 673
2019
Q2 		$155K Buy
+19,400
New +$130K 0.01% 582

Other funds holding NTRP

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFAS
Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return
PTP
Platform Technology Partners New York $519M AUM 20% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM

Caption Management's NTRP Position: Q1 2020 in Review

Caption Management sold out of Neurotrope, Inc. Common (NTRP) in Q1 2020, closing a stake of 6,200 shares — an estimated $6K sold.

Caption Management first reported a position in NTRP in Q2 2019 and held it in 2 quarters. The position peaked at $105K in Q2 2019. 28 funds tracked by Wall St. Rank hold NTRP as of Q1 2020.

  • Caption Management reported no remaining Neurotrope, Inc. Common position as of Q1 2020 after selling out during the quarter.
  • Caption Management sold 6,200 Neurotrope, Inc. Common shares in Q1 2020, an estimated $6K.
  • Caption Management first reported a position in Neurotrope, Inc. Common in Q2 2019 and held it in 2 quarters.
  • Caption Management's Neurotrope, Inc. Common position peaked at $105K in Q2 2019.
  • 28 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q1 2020.

Based on Caption Management's 13F filing for Q1 2020, filed 15 May 2020.